. ♪ >>> time for cramer and stop trading. >> 14 times earnings with high single digit growth on the top line and double digit growth on the bottom line, i'm talking about allergan, brent saunders delivering what i think is a terrific quarter. he talks about how one day he's not going to be a long-term holder of the teva he got. been reduced dramatically when he got it from selling generics. but talking about not putting through big price increases, president trump should listen to that call or summary of it. the guidance, he reset everything back when the stock went down to 180 from what he was saying about the pfizer memo. and now he's got six drugs that are about to come out that he thinks could be big. a lot of stuff in the pipe. and i've got to tell you, this is going to be the new favorite of the growth guys given the come-ups of the gileads. >> pursuing different strategy of peers going after smaller companies. people recall that incredible premium they paid but a small number for a deal not long ago. >> for life cell. >> these are going to be the way they go. >> right. >> because